急性虚血性脳卒中診断の世界市場レポート 2025年

急性虚血性脳卒中診断の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は7.1％で、32億7,000万米ドルに成長します。予測期間の成長は、遠隔モニタリング技術、患者中心のヘルスケアモデル、ウェアラブルデバイスの統合、ポイントオブケア検査機器、モバイル脳卒中ユニットの拡大などに起因します。予測期間の主な動向には、画像技術の進歩、人工知能の進歩、遺伝子およびバイオマーカー製品の革新、データセキュリティのためのブロックチェーン、拡張現実の統合などが含まれます。

急性虚血性脳卒中症例の増加は、今後の急性虚血性脳卒中診断市場の成長を促進すると予測されます。急性虚血性脳卒中は、脳への血流不全によって引き起こされ、脳細胞の死につながる重大な医療緊急事態です。急性虚血性脳梗塞の適時診断は、効果的な治療と脳梗塞による脳損傷やその他の合併症を最小限に抑えるために極めて重要です。例えば、2024年4月に英国を拠点とする慈善団体である脳卒中協会が発表したマニフェストでは、英国における脳卒中のコストは来年の430億ポンドから2035年までに750億ポンドに増加すると予測されており、20年間で200％近く増加することが示されています。さらに、脳卒中の4人に1人が労働年齢に影響を及ぼし、年間16億英ポンドの生産性損失が予想され、これは2035年までに136％増加すると予測されています。このように、急性虚血性脳卒中の有病率の上昇が、急性虚血性脳卒中診断市場の成長を促進しています。

急増する高齢者層は、近い将来、急性虚血性脳卒中診断市場の成長に大きく貢献するものと思われます。65歳以上の個人と定義されるこの人口層は、複数の慢性疾患の蔓延や身体的制限など、加齢プロセスに伴う脆弱性と相まって、明確な健康・社会的要件を備えています。高齢者層は、若い年齢層に比べて感受性が高いため、急性虚血性脳卒中診断において極めて重要な役割を担っています。急性虚血性脳卒中診断で重要なのは、早期発見、治療方法、同時進行する健康状態です。例えば、2022年10月に世界保健機関（WHO）が発表した洞察によると、2030年までに世界の6人に1人が60歳を超え、2020年の10億人から14億人に達します。さらに、世界の60歳以上の人口は2050年までに21億人に倍増し、この間にさらに4億2,600万人が80歳の節目を超えると予測されています。したがって、急増する高齢者人口は、急性虚血性脳卒中診断市場の拡大を推進する重要なカタリストとなっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の急性虚血性脳卒中診断 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の急性虚血性脳卒中診断市場：成長率分析
• 世界の急性虚血性脳卒中診断市場の実績：規模と成長, 2019-2024
• 世界の急性虚血性脳卒中診断市場の予測：規模と成長, 2024-2029, 2034F
• 世界の急性虚血性脳卒中診断総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の急性虚血性脳卒中診断市場：診断タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンピュータ断層撮影（CT）
• 磁気共鳴画像（MRI）
• 頸動脈超音波検査
• 脳血管造影検査
• 心電図検査（ECG）
• 心エコー検査
• その他の診断
• 世界の急性虚血性脳卒中診断市場：手術タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 頸動脈内膜切除術
• 血管形成術
• 血管内機械的血栓除去術
• 世界の急性虚血性脳卒中診断市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組織プラスミノーゲン活性化因子（TPA）
• 抗凝固剤
• 抗血小板薬
• 降圧剤
• 世界の急性虚血性脳卒中診断市場、タイプ別サブセグメンテーション：コンピュータ断層撮影（CT）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非造影CT
• CT血管造影検査
• 世界の急性虚血性脳卒中診断市場、タイプ別サブセグメンテーション：磁気共鳴画像（MRI）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 拡散強調画像（DWI）を用いたMRI
• MRI血管造影検査
• 世界の急性虚血性脳卒中診断市場、タイプ別サブセグメンテーション：頸動脈超音波、実績と予測, 2019-2024, 2024-2029F, 2034F
• ドップラー超音波
• Bモード超音波
• 世界の急性虚血性脳卒中診断市場、タイプ別サブセグメンテーション：脳血管造影、実績と予測, 2019-2024, 2024-2029F, 2034F
• デジタルサブトラクション血管造影（DSA）
• カテーテル血管造影
• 世界の急性虚血性脳卒中診断市場、タイプ別サブセグメンテーション：心電図（ECG）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準心電図
• ホルターモニタリング
• 世界の急性虚血性脳卒中診断市場、タイプ別サブセグメンテーション：心エコー検査、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経胸壁心エコー検査（TTE）
• 経食道心エコー検査（TEE）
• 世界の急性虚血性脳卒中診断市場、タイプ別サブセグメンテーション：その他の診断、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液検査
• 神経学的検査
• CT灌流

第7章 地域別・国別分析

• 世界の急性虚血性脳卒中診断市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の急性虚血性脳卒中診断市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 急性虚血性脳卒中診断市場：競合情勢
• 急性虚血性脳卒中診断市場：企業プロファイル
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi-Aventis LLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Abbott Laboratories
• Medtronic plc
• Siemens Healthineers AG
• Philips Healthcare
• Stryker Corporation
• GE HealthCare Technologies Inc.
• Boston Scientific Corporation
• Genentech Inc.
• Nihon Kohden Corporation
• Neusoft Medical Systems Co. Ltd.
• Penumbra Inc.
• Insera Therapeutics LLC
• MicroVention Inc.
• FUJIFILM Medical Systems
• Canon Medical Systems Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 急性虚血性脳卒中診断市場2029：新たな機会を提供する国
• 急性虚血性脳卒中診断市場2029：新たな機会を提供するセグメント
• 急性虚血性脳卒中診断市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

An acute ischemic stroke (AIS) diagnosis involves identifying a medical condition characterized by a sudden loss of blood flow to a specific part of the brain, leading to a loss of neurological function. The diagnostic process aims to pinpoint and understand the origins of the clot responsible for the abrupt reduction in blood flow.

The primary types of acute ischemic stroke diagnosis include computed tomography (CT), magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography (ECG), echocardiography, and other relevant methods. Computed tomography (CT) involves the creation of detailed images of various body parts using computer technology connected to an X-ray machine. Various types of surgeries are associated with acute ischemic stroke treatment, including carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy. These surgical procedures find application in various treatment approaches, such as the use of tissue plasminogen activator (TPA), anticoagulants, antiplatelet medications, and antihypertensive drugs.

The acute ischemic stroke diagnosis market research report is one of a series of new reports from The Business Research Company that provides acute ischemic stroke diagnosis market statistics, including acute ischemic stroke diagnosis industry global market size, regional shares, competitors with an acute ischemic stroke diagnosis market share, detailed acute ischemic stroke diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the acute ischemic stroke diagnosis industry. This acute ischemic stroke diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute ischemic stroke diagnosis market size has grown strongly in recent years. It will grow from $2.32 billion in 2024 to $2.48 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rise in cardiovascular risk factors, telemedicine adoption, establishment of stroke centers, increased aging population, development of thrombolytic therapies

The acute ischemic stroke diagnosis market size is expected to see strong growth in the next few years. It will grow to $3.27 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to remote monitoring technologies, patient-centric healthcare models, integration of wearable devices, point-of-care testing devices, expansion of mobile stroke units. Major trends in the forecast period include advancements in imaging technologies, advancements in artificial intelligence, genetic and biomarker product innovations, blockchain for data security, integration of augmented reality.

The increasing incidence of acute ischemic stroke cases is anticipated to drive the growth of the acute ischemic stroke diagnosis market in the future. Acute ischemic stroke is a critical medical emergency caused by inadequate blood flow to the brain, leading to brain cell death. Timely diagnosis of acute ischemic stroke is crucial for effective treatment and minimizing brain damage and other complications resulting from the stroke. For example, in April 2024, a manifesto released by the Stroke Association, a UK-based charity, projected that the cost of stroke in the UK will rise from £43 billion next year to £75 billion by 2035, indicating nearly a 200% increase over 20 years. Additionally, 1 in 4 strokes will affect working-age individuals, leading to an expected annual productivity loss of £1.6 billion, which is projected to grow by 136% by 2035. Thus, the rising prevalence of acute ischemic stroke cases is propelling the growth of the acute ischemic stroke diagnosis market.

The burgeoning elderly demographic is poised to significantly contribute to the growth of the acute ischemic stroke diagnosis market in the foreseeable future. Defined as individuals aged 65 and above, this demographic segment presents distinct health and social requisites coupled with vulnerabilities associated with the aging process, such as the prevalence of multiple chronic ailments and physical limitations. The elderly demographic assumes a pivotal role in acute ischemic stroke diagnosis, primarily due to their heightened susceptibility compared to younger age groups. Key facets crucial in acute ischemic stroke diagnosis encompass early identification, treatment modalities, and concurrent health conditions. For instance, insights from the World Health Organization in October 2022 indicated that by 2030, 1 in every 6 individuals globally will surpass 60 years of age, reaching a tally of 1.4 billion, up from 1 billion in 2020. Moreover, the worldwide population aged 60 and above is projected to double to 2.1 billion by 2050, with an additional 426 million individuals expected to cross the 80-year milestone during this period. Hence, the burgeoning elderly populace is a significant catalyst propelling the expansion of the acute ischemic stroke diagnosis market.

The acute ischemic stroke diagnosis market is witnessing a prominent trend favoring product innovations, capturing widespread attention. Leading companies within this domain are dedicatedly engaged in pioneering novel products to uphold their market standing. An exemplary instance occurred in February 2022 when Imperative Care Inc., a US-based manufacturer of medical equipment, unveiled the Zoom POD Aspiration Tubing-an innovative advancement aimed at enhancing stroke therapy. Distinguished as the first sterile field clot filter device, the Zoom POD facilitates expedited mechanical thrombectomy procedures for individuals afflicted with ischemic stroke. This groundbreaking device integrates seamlessly into the aspiration tube, significantly reducing the distance between aspiration and filtration while maintaining optimal aspiration strength. The Zoom POD expedites a critical phase of treatment by providing swift visualization to physicians, confirming efficient clot removal, thereby streamlining the therapeutic process.

Major players in the acute ischemic stroke diagnosis market are strategically forging partnerships to gain a competitive edge. These collaborations are strategically aimed at bolstering the development and accessibility of cutting-edge diagnostic tools crucial for accurate and timely stroke diagnosis. Notably, in October 2023, Brainomix Ltd., a US-based medtech company powered by AI solutions, joined forces with Nanoflex Robotics AG, a Switzerland-based developer specializing in soft robotic systems. Their partnership targets the creation of an AI robotics platform dedicated to acute ischemic stroke treatment. This innovative platform involves AI-assisted magnetic navigation systems tailored for stroke-related robotic surgical tools. The amalgamation of their technologies aims to introduce an AI-driven navigation tool facilitating catheters and other devices in navigating the vascular system. This collaborative project aspires to leverage artificial intelligence to enhance Nanoflex Robotics' advanced magnetic robotic navigation system, potentially pioneering remote thrombectomy-a groundbreaking shift in stroke therapy possibilities. This groundbreaking endeavor is anticipated to significantly impact stroke therapy, potentially enhancing patient outcomes by revolutionizing the treatment landscape.

In November 2022, Visionable Ltd., a UK-based videoconferencing platform, announced a strategic partnership with Brainomix. The aim of this collaboration is to improve stroke care delivery by integrating Visionable's virtual healthcare platform with Brainomix's AI-powered e-Stroke imaging. This integration is designed to enhance diagnosis, treatment efficiency, and patient outcomes throughout the stroke care pathway. Brainomix is a UK-based digital health company that focuses on AI-driven imaging biomarkers and software solutions.

Major companies operating in the acute ischemic stroke diagnosis market include Cardinal Health Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Sanofi-Aventis LLC, Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Philips Healthcare, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Genentech Inc., Nihon Kohden Corporation, Neusoft Medical Systems Co. Ltd., Penumbra Inc., Insera Therapeutics LLC, MicroVention Inc., FUJIFILM Medical Systems, Canon Medical Systems Corporation, Silk Road Medical Inc., Samsung Neurologica Corporation, Mentice AB, NICO Corporation, Imperative Care Inc., Olea Medical, NovaSignal Corporation, iSchemaView Inc., Hyperfine Research Inc., Perfuze Ltd.

North America was the largest region in the acute ischemic stroke diagnosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute ischemic stroke diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the acute ischemic stroke diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acute ischemic stroke (AIS) diagnosis market includes revenues earned by entities through physical exams, thrombolysis, blood tests, and other imaging techniques. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Ischemic Stroke Diagnosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute ischemic stroke diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute ischemic stroke diagnosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute ischemic stroke diagnosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Diagnostic Type: Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Carotid Ultrasound; Cerebral Angiography; Electrocardiography (ECG); Echocardiography; Other Diagnostics
• 2) By Surgery Type: Carotid Endarterectomy; Angioplasty; Endovascular Mechanical Thrombectomy
• 3) By Application: Tissue Plasminogen Activator (TPA); Anticoagulant; Antiplatelet; Antihypertensive
• Subsegments:
• 1) By Computed Tomography (CT): Non-Contrast CT; CT Angiography
• 2) By Magnetic Resonance Imaging (MRI): MRI With Diffusion-Weighted Imaging (DWI); MRI Angiography
• 3) By Carotid Ultrasound: Doppler Ultrasound; B-Mode Ultrasound
• 4) By Cerebral Angiography: Digital Subtraction Angiography (DSA); Catheter Angiography
• 5) By Electrocardiography (ECG): Standard ECG; Holter Monitoring
• 6) By Echocardiography: Transthoracic Echocardiography (TTE); Transesophageal Echocardiography (TEE)
• 7) By Other Diagnostics: Blood Tests; Neurological Examination; CT Perfusion
• Companies Mentioned: Cardinal Health Inc.; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Bayer AG; Sanofi-Aventis LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acute Ischemic Stroke Diagnosis Market Characteristics

3. Acute Ischemic Stroke Diagnosis Market Trends And Strategies

4. Acute Ischemic Stroke Diagnosis Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Acute Ischemic Stroke Diagnosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Acute Ischemic Stroke Diagnosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Acute Ischemic Stroke Diagnosis Market Growth Rate Analysis
• 5.4. Global Acute Ischemic Stroke Diagnosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Acute Ischemic Stroke Diagnosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Acute Ischemic Stroke Diagnosis Total Addressable Market (TAM)

6. Acute Ischemic Stroke Diagnosis Market Segmentation

• 6.1. Global Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Carotid Ultrasound
• Cerebral Angiography
• Electrocardiography (ECG)
• Echocardiography
• Other Diagnostics
• 6.2. Global Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carotid Endarterectomy
• Angioplasty
• Endovascular Mechanical Thrombectomy
• 6.3. Global Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tissue Plasminogen Activator (TPA)
• Anticoagulant
• Antiplatelet
• Antihypertensive
• 6.4. Global Acute Ischemic Stroke Diagnosis Market, Sub-Segmentation Of Computed Tomography (CT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Contrast CT
• CT Angiography
• 6.5. Global Acute Ischemic Stroke Diagnosis Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• MRI With Diffusion-Weighted Imaging (DWI)
• MRI Angiography
• 6.6. Global Acute Ischemic Stroke Diagnosis Market, Sub-Segmentation Of Carotid Ultrasound, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Doppler Ultrasound
• B-Mode Ultrasound
• 6.7. Global Acute Ischemic Stroke Diagnosis Market, Sub-Segmentation Of Cerebral Angiography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Digital Subtraction Angiography (DSA)
• Catheter Angiography
• 6.8. Global Acute Ischemic Stroke Diagnosis Market, Sub-Segmentation Of Electrocardiography (ECG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard ECG
• Holter Monitoring
• 6.9. Global Acute Ischemic Stroke Diagnosis Market, Sub-Segmentation Of Echocardiography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transthoracic Echocardiography (TTE)
• Transesophageal Echocardiography (TEE)
• 6.10. Global Acute Ischemic Stroke Diagnosis Market, Sub-Segmentation Of Other Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tests
• Neurological Examination
• CT Perfusion

7. Acute Ischemic Stroke Diagnosis Market Regional And Country Analysis

• 7.1. Global Acute Ischemic Stroke Diagnosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Acute Ischemic Stroke Diagnosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acute Ischemic Stroke Diagnosis Market

• 8.1. Asia-Pacific Acute Ischemic Stroke Diagnosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acute Ischemic Stroke Diagnosis Market

• 9.1. China Acute Ischemic Stroke Diagnosis Market Overview
• 9.2. China Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acute Ischemic Stroke Diagnosis Market

• 10.1. India Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acute Ischemic Stroke Diagnosis Market

• 11.1. Japan Acute Ischemic Stroke Diagnosis Market Overview
• 11.2. Japan Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acute Ischemic Stroke Diagnosis Market

• 12.1. Australia Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acute Ischemic Stroke Diagnosis Market

• 13.1. Indonesia Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acute Ischemic Stroke Diagnosis Market

• 14.1. South Korea Acute Ischemic Stroke Diagnosis Market Overview
• 14.2. South Korea Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acute Ischemic Stroke Diagnosis Market

• 15.1. Western Europe Acute Ischemic Stroke Diagnosis Market Overview
• 15.2. Western Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acute Ischemic Stroke Diagnosis Market

• 16.1. UK Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acute Ischemic Stroke Diagnosis Market

• 17.1. Germany Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acute Ischemic Stroke Diagnosis Market

• 18.1. France Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acute Ischemic Stroke Diagnosis Market

• 19.1. Italy Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acute Ischemic Stroke Diagnosis Market

• 20.1. Spain Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acute Ischemic Stroke Diagnosis Market

• 21.1. Eastern Europe Acute Ischemic Stroke Diagnosis Market Overview
• 21.2. Eastern Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acute Ischemic Stroke Diagnosis Market

• 22.1. Russia Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acute Ischemic Stroke Diagnosis Market

• 23.1. North America Acute Ischemic Stroke Diagnosis Market Overview
• 23.2. North America Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acute Ischemic Stroke Diagnosis Market

• 24.1. USA Acute Ischemic Stroke Diagnosis Market Overview
• 24.2. USA Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acute Ischemic Stroke Diagnosis Market

• 25.1. Canada Acute Ischemic Stroke Diagnosis Market Overview
• 25.2. Canada Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acute Ischemic Stroke Diagnosis Market

• 26.1. South America Acute Ischemic Stroke Diagnosis Market Overview
• 26.2. South America Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acute Ischemic Stroke Diagnosis Market

• 27.1. Brazil Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acute Ischemic Stroke Diagnosis Market

• 28.1. Middle East Acute Ischemic Stroke Diagnosis Market Overview
• 28.2. Middle East Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acute Ischemic Stroke Diagnosis Market

• 29.1. Africa Acute Ischemic Stroke Diagnosis Market Overview
• 29.2. Africa Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acute Ischemic Stroke Diagnosis Market Competitive Landscape And Company Profiles

• 30.1. Acute Ischemic Stroke Diagnosis Market Competitive Landscape
• 30.2. Acute Ischemic Stroke Diagnosis Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi-Aventis LLC Overview, Products and Services, Strategy and Financial Analysis

31. Acute Ischemic Stroke Diagnosis Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Medtronic plc
• 31.3. Siemens Healthineers AG
• 31.4. Philips Healthcare
• 31.5. Stryker Corporation
• 31.6. GE HealthCare Technologies Inc.
• 31.7. Boston Scientific Corporation
• 31.8. Genentech Inc.
• 31.9. Nihon Kohden Corporation
• 31.10. Neusoft Medical Systems Co. Ltd.
• 31.11. Penumbra Inc.
• 31.12. Insera Therapeutics LLC
• 31.13. MicroVention Inc.
• 31.14. FUJIFILM Medical Systems
• 31.15. Canon Medical Systems Corporation

32. Global Acute Ischemic Stroke Diagnosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acute Ischemic Stroke Diagnosis Market

34. Recent Developments In The Acute Ischemic Stroke Diagnosis Market

35. Acute Ischemic Stroke Diagnosis Market High Potential Countries, Segments and Strategies

• 35.1 Acute Ischemic Stroke Diagnosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Acute Ischemic Stroke Diagnosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Acute Ischemic Stroke Diagnosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer